4-(4-Methyl-5-nitropyridin-2-yl)morpholine, 98%, 5g

N-(1-(7,8-Dihydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine hydrochloride, 98%, 10mg

O-Butylhydroxylamine Hydrochloride>98.0%(N)(T)5g

dNTP-Set 3, 5 x 4 x 25 µmol

2-(PIPERIDIN-4-YLSULFANYL)PYRIDINE 2HCL, 95.0%, 5g

N-[Tris(hydroxymethyl)methyl]-3-amino-2-hydroxypropanesulfonic acid (TAPSO), 99.0%, 100g

Ethyl 4,4,4-Trifluorobutyrate>98.0%(GC)1g

2-fluoro-5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol, 95.0%, 1g

4-Decenoic Acid, 98.0%, 1g

4-Morpholin-4-ylmethyl-phenylamine, 95.0%, 5g

2-Methyl-4'-(methylthio)-2-morpholinopropiophenone>98.0%(GC)(T)25g

2',5'-Difluoroacetophenone, 98.0%, 25g

1-Methylxanthine>97.0%(HPLC)(T)50mg